Department of Chemistry & Chemical Biology, Indian Institute of Technology (ISM) Dhanbad, Dhanbad 826004, India.
J Phys Chem B. 2022 May 19;126(19):3477-3492. doi: 10.1021/acs.jpcb.1c10278. Epub 2022 May 9.
Catechol -methyltransferase (COMT) plays a vital role in deactivating neurotransmitters like dopamine, norepinephrine, etc., by methylating those compounds. However, the deactivation of an excess amount of neurotransmitters leads to serious mental ailments such as Parkinson's disease. Molecules that bind inside the enzyme's active site inhibit this methylation mechanism by methylating themselves, termed COMT inhibitors. Our study is focused on designing these inhibitors by various machine learning methods. First, we have developed a classification model with experimentally available COMT inhibitors, which helped us generate a new data set of small inhibitor-like molecules. Then, to predict the activity of the new molecules, we have applied regression techniques such as Random Forest, AdaBoost, gradient boosting, and support vector machines. Each of the regression models yielded an value > 70% for both training and test data sets. Finally, to validate our models, 200 ns long molecular dynamics (MD) simulations of the two known inhibitors with known IC values and the resultant inhibitors were performed inside the binding pockets to check their stability within. The free energy barrier of the methyl transfer from -adenosyl-l-methionine (SAM) to each inhibitor was determined by combining steered molecular dynamics (SMD) and umbrella sampling using the quantum mechanics/molecular mechanics (QM/MM) method.
儿茶酚-O-甲基转移酶(COMT)通过甲基化来使多巴胺、去甲肾上腺素等神经递质失活,从而发挥着至关重要的作用。然而,过量神经递质的失活会导致严重的精神疾病,如帕金森病。结合到酶的活性部位内的分子通过自身甲基化来抑制这种甲基化机制,被称为 COMT 抑制剂。我们的研究集中于使用各种机器学习方法来设计这些抑制剂。首先,我们使用现有的 COMT 抑制剂开发了一个分类模型,这有助于我们生成一个新的小分子抑制剂数据集。然后,为了预测新分子的活性,我们应用了回归技术,如随机森林、自适应增强、梯度提升和支持向量机。每个回归模型在训练和测试数据集上的 值均>70%。最后,为了验证我们的模型,我们在结合位点对两个已知抑制剂和已知 IC 值的抑制剂以及由此产生的抑制剂进行了 200ns 长的分子动力学(MD)模拟,以检查它们在结合口袋内的稳定性。通过使用量子力学/分子力学(QM/MM)方法结合定向分子动力学(SMD)和伞状采样,确定了从 -腺嘌呤基-L-甲硫氨酸(SAM)到每个抑制剂的甲基转移的自由能势垒。